Gunnar Gottschalk: Difference between revisions
m (Text replacement - "Talks and Interviews" to "Talks and interviews") |
Notjusttired (talk | contribs) m (Text replacement - " author-link9=" to " author-link9 = ") |
||
(178 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
[[File:Gunnar Gottschalk.png|200px|thumb|right|Source:Simmaron Research]] | [[File:Gunnar Gottschalk.png|200px|thumb|right|Source:Simmaron Research]] | ||
'''C. Gunnar Gottschalk''', | '''C. Gunnar Gottschalk''', Ph.D is a member of Board of Directors at [[Simmaron Research]], a non-profit organization based in Incline Village, Nevada, which works to advance translational science in treating neuroimmune diseases like CFS/ME.<ref>{{Cite web | url = http://simmaronresearch.com/staff-board/ | title = Board of Directors|website=Simmaron Research|language=en-US|access-date=2019-09-03}}</ref> | ||
In 2012, Gottschalk was the Clinical Coordinator for years I and II of the [[CDC]] Multi-site Clinical Assessment of CFS. The project's aim was to characterize patients with CFS or myalgic encephalomyelitis (ME) in clinical practices of clinicians with expertise in CFS/ME.<ref>http://www.cdc.gov/cfs/programs/clinical-assessment/</ref> Team members included [[Andreas Kogelnik]], [[Lucinda Bateman]], and [[Nancy Klimas]].<ref>https://www.linkedin.com/in/gunnar-gottschalk-86b29837</ref> | In 2012, Gottschalk was the Clinical Coordinator for years I and II of the [[Centers for Disease Control and Prevention|CDC]] Multi-site Clinical Assessment of CFS. The project's aim was to characterize patients with CFS or myalgic encephalomyelitis (ME) in clinical practices of clinicians with expertise in CFS/ME.<ref>http://www.cdc.gov/cfs/programs/clinical-assessment/</ref> Team members included [[Andreas Kogelnik]], [[Lucinda Bateman]], and [[Nancy Klimas]].<ref>https://www.linkedin.com/in/gunnar-gottschalk-86b29837</ref> | ||
In 2012, Gottschalk was the Cohort Recruitment Project Clinical Coordinator at the Chronic Fatigue Initiative at the Hutchins Family Foundation for the project to develop a clinical and biosample database to enable discovery of pathogens and pathogenic mechanisms in [[Chronic Fatigue Syndrome]].<ref>http://cfinitiative.org/research-programs/</ref> | In 2012, Gottschalk was the Cohort Recruitment Project Clinical Coordinator at the Chronic Fatigue Initiative at the Hutchins Family Foundation for the project to develop a clinical and biosample database to enable discovery of pathogens and pathogenic mechanisms in [[Chronic Fatigue Syndrome]].<ref>http://cfinitiative.org/research-programs/</ref> | ||
Line 10: | Line 10: | ||
*2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="KlimasNG, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | *2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="KlimasNG, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] | ||
*2015, [[Chronic fatigue syndrome]] and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)] | *2015, [[Chronic fatigue syndrome]] and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)] | ||
* 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness<ref>{{Cite journal|last1=Hornig|first1=M| | * 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness<ref>{{Cite journal | last1 = Hornig | first1 = M | authorlink = Mady Hornig | last2 = Montoya | first2 = JG | authorlink2 = Jose Montoya | last3 = Klimas | first3 = NG | authorlink3 = Nancy Klimas | last4 = Levine | first4 = SM | authorlink4 = Susan Levine | last5 = Felsenstein | first5 = D | authorlink5 = Donna Felsenstein | last6 = Bateman | first6 = L | authorlink6=Lucinda Bateman | last7 = Peterson | first7 = DL | authorlink7 = Daniel Peterson | last8 = Gottschalk | first8 = CG | author-link8 = Gunnar Gottschalk | last9 = Schultz|first9 = AF | author-link9 = Andrew Schultz | last10 = Che | first10 = X | authorlink10=Xiaoyu Che | last11 = Eddy | first11 = ML | authorlink11=Meredith Eddy | last12 = Komaroff | first12 = AL | authorlink12=Anthony Komaroff | last13 = Lipkin | first13 = WI | authorlink13 = Ian Lipkin | title = Distinct plasma immune signatures in ME/CFS are present early in the course of illness|journal=Science Advances|volume=1|issue=1 | page = | date = 2015 | pmid = |doi =10.1126/sciadv.1400121 | url = http://advances.sciencemag.org/content/1/1/e1400121.full}}</ref> - [https://advances.sciencemag.org/content/1/1/e1400121 (Full text)] | ||
*2016, [[Cytokine]] network analysis of cerebrospinal fluid in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Hornig, 2016" /> [https://www.nature.com/articles/mp201529 (Abstract)] | *2016, [[Cytokine]] network analysis of cerebrospinal fluid in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Hornig, 2016" /> [https://www.nature.com/articles/mp201529 (Abstract)] | ||
*2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> [https://academic.oup.com/aje/article/185/8/617/3073694 (Full Text)] | *2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> [https://academic.oup.com/aje/article/185/8/617/3073694 (Full Text)] | ||
*2017, Immune network analysis of cerebrospinal fluid in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] with atypical and classical presentations<ref name="Hornig, 2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416687/ (Full Text)] | *2017, Immune network analysis of cerebrospinal fluid in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] with atypical and classical presentations<ref name="Hornig, 2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416687/ (Full Text)] | ||
*2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations<ref name="Mandarano2020">{{Cite journal | last = Mandarano | first = Alexandra H. | authorlink = Alexandra Mandarano | last2 = Maya | first2 = Jessica | authorlink2 = | last3 = Giloteaux | first3 = Ludovic | authorlink3 = Ludovic Giloteaux | last4 = Peterson | first4 = Daniel L. | authorlink4 = Daniel Peterson | last5 = Maynard | first5 = Marco | authorlink5 = | last6 = Gottschalk | first6 = C. Gunnar | authorlink6 = Gunnar Gottschalk | last7 = Hanson | first7 = Maureen R. | authorlink7 = Maureen Hanson | date = 2020-03-02 | title = Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations| url = https://pubmed.ncbi.nlm.nih.gov/31830003/|journal=The Journal of Clinical Investigation|volume=130|issue=3 | pages = 1491–1505|doi=10.1172/JCI132185|issn=1558-8238|pmc=7269566|pmid=31830003|access-date=|quote=|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269566 (Full text)] | |||
==Talks and interviews== | ==Talks and interviews== | ||
Line 31: | Line 32: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="BatemanL, 2015">{{Citation | <ref name="BatemanL, 2015">{{Citation | last = Bateman | first1 = L. | authorlink1 = Lucinda Bateman | last2 = Darakjy | first2 = S. | authorlink2 = | last3 = Klimas | first3 = N. | authorlink3 = Nancy Klimas | last4 = Peterson | first4 =D. | authorlink4 = Daniel Peterson | last5 = Levine | first5 = S.M. | authorlink5 = Susan Levine | last6 = Allen | first6 = A. | authorlink6 = | last7 = Carlson | first7 = S.A. | authorlink7 = | last8 = Balbin | first8 = E.G. | author-link8 = Elizabeth Balbin | last9 = Gottschalk | first9 = G. | author-link9 = Gunnar Gottschalk | last10 = March | first10 =D. | authorlink10 = | title = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 1 | page = 1-15 | date = 2015 | pmid = | doi = 10.1080/21641846.2014.978109 }}</ref> | ||
| | <ref name="Hornig, 2016">{{Citation | last = Hornig | first1 = M | authorlink1 = Mady Hornig | last2 = Gottschalk | first2 = G | authorlink2 = Gunnar Gottschalk | last3 = Peterson | first3 = D | authorlink3 = Daniel Peterson | last4 = Knox | first4 = KK | authorlink4 = | last5 = Schultz | first5 = AF | authorlink5 = | last6 =Eddy | first6 = ML | authorlink6 = | last7 = Che | first7 = X | authorlink7 = | last8 = Lipkin | first8 = WI | author-link8 = Ian Lipkin | title = Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. | journal = Molecular Psychiatry | volume = 21 | issue = 2 | page = 261-9 | date = 2016 | doi = 10.1038/mp.2015.29 }}</ref> | ||
| last2 | <ref name="Hornig, 2017">{{Citation | last = Hornig | first1 = M | authorlink1 = Mady Hornig | last2 = Gottschalk | first2 = G | authorlink2 = Gunnar Gottschalk | last3 = Eddy | first3 = ML | authorlink3 = | last4 = Che | first4 = X | authorlink4 = | last5 = Ukaigwe | first5 = JE | authorlink5 = | last6 = Peterson | first6 = DL | authorlink6 = Daniel Peterson | last7 = Lipkin | first7 = WI | authorlink7 = Ian Lipkin | title = Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations | journal = Translational Psychiatry | volume = 7 | issue = 4 | page = | date = 2017 | doi = 10.1038/tp.2017.44 }}</ref> | ||
| last3 | <ref name="KlimasNG, 2015">{{Citation | last = Klimas | first1 = N.G. | authorlink1 = Nancy Klimas | last2 = Ironson | first2 = G. | authorlink2 = | last3 = Carter | first3 = A. | authorlink3 = | last4 = Balbin | first4 = E. | authorlink4 = Elizabeth Balbin | last5 = Bateman | first5 = L. | authorlink5 = Lucinda Bateman | last6 =Felsenstein | first6 =D. | authorlink6 = Donna Felsenstein | last7 = Levine | first7 = S. | authorlink7 = Susan Levine | last8 = Peterson | first8 =D. | author-link8 = Daniel Peterson | last9 =Chiu | first9 = K. | author-link9 = | last10 = Allen | first10 = A. | authorlink10 = | last11 = Cunningham | first11 = K. | authorlink11 = | last12 = Gottschalk | first12 = C.G. | authorlink12 = Gunnar Gottschalk | last13 = Fletcher | first13 = M | authorlink13 = Mary Ann Fletcher | last14 = Hornig | first14 = M. | authorlink14 = Mady Hornig | last15 = Canning | first15 = C. | authorlink15 = | last16 = Komaroff | first16 = A.L. | authorlink16 = Anthony Komaroff | title = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome | journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 2 | page = 75-96 | date = 2015 | pmid = | doi = 10.1080/21641846.2015.1023652 }}</ref> | ||
| last4 | <ref name="Peterson, 2015">{{Citation | last = Peterson | first1 = D | authorlink1 = Daniel Peterson | last2 = Brenu | first2 = EW | authorlink2 = Ekua Brenu | last3 = Gottschalk | first3 = G | authorlink3 = Gunnar Gottschalk | last4 = Ramos | first4 = SB | authorlink4 = Sandra Ramos | last5 = Nguyen | first5 = T | authorlink5 = | last6 = Staines | first6 = D | authorlink6 = Donald Staines | last7 = Marshall-Gradisnik | first7 = S | authorlink7 = Sonya Marshall-Gradisnik | title = Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | journal = Mediators of Inflammation | volume = 2015 | issue = | page = | date = 2015 | doi = 10.1155/2015/929720 }}</ref> | ||
| last5 | <ref name="Unger, 2017">{{Citation | last = Unger | first1 = Elizabeth R. | authorlink1 = Elizabeth Unger | last2 = Lin | first2 = Jin-Mann S. | authorlink2 = Jin-Mann Sally Lin | last3 = Tian | first3 = Hao | authorlink3 = | last4 = Natelson | first4 = Benjamin H | authorlink4 = Benjamin Natelson | last5 = Lange | first5 = Gudrun | authorlink5 = Gudrun Lange | last6 = Vu | first6 = Diana | authorlink6 = | last7 = Blate | first7 = Michelle | authorlink7 = | last8 = Klimas | first8 = Nancy G. | author-link8 = Nancy Klimas | last9 =Balbin | first9 = Elizabeth G. | author-link9 = Elizabeth Balbin | last10 =Bateman | first10 = Lucinda | authorlink10 = Lucinda Bateman | last11 = Allen | first11 = Ali | authorlink11 = | last12 = Lapp | first12 = Charles W. | authorlink12 = Charles Lapp | last13 =Springs | first13 = Wendy | authorlink13 = | last14 = Kogelnik | first14 = Andreas M. | authorlink14 = Andreas Kogelnik | last15 = Phan | first15 = Catrina C. | authorlink15 = | last16 = Danver | first16 = Joan | authorlink16 = | last17 = Podell | first17 = Richard N. | authorlink17 = Richard Podell | last18 = Fitzpatrick | first18 = Trisha | authorlink18 = | last19 = Peterson | first19 = Daniel L. | authorlink19 = Daniel Peterson | last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan | last22 = MCAM Study Group | first22 = | authorlink22 = | title = Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study. | journal = American Journal of Epidemiology | volume = 1-10 | issue = | page = | date = 2017 | pmid = | doi = 10.1093/aje/kwx029 }}</ref> | ||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Hornig, 2016">{{Citation | |||
| | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| title | |||
| journal = Molecular Psychiatry | |||
| date | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Hornig, 2017">{{Citation | |||
| | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| title | |||
| journal = Translational Psychiatry | |||
| date | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="KlimasNG, 2015">{{Citation | |||
| | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| title | |||
| journal = Fatigue: Biomedicine, Health & Behavior | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Peterson, 2015">{{Citation | |||
| | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| title | |||
| journal = Mediators of Inflammation | |||
| date | |||
| doi | |||
}} | |||
</ref> | |||
<ref name="Unger, 2017">{{Citation | |||
| | |||
| last2 | |||
| last3 | |||
| last4 | |||
| last5 | |||
| last6 | |||
| last7 | |||
| last8 | |||
| last9 | |||
| last10 | |||
| last11 | |||
| last12 | |||
| last13 | |||
| last14 | |||
| last15 | |||
| last16 | |||
| last17 | |||
| last18 | |||
| last19 | |||
| last20 | |||
| last21 = Rajeevan | |||
| last22 | |||
| title | |||
| journal = American Journal of Epidemiology | |||
| date | |||
| pmid | |||
| doi | |||
}} | |||
</ref> | |||
</references> | </references> | ||
[[Category:Researchers]] | [[Category:Researchers]] | ||
[[Category:US researchers]] | [[Category:US researchers]] |
Latest revision as of 14:10, April 2, 2023
C. Gunnar Gottschalk, Ph.D is a member of Board of Directors at Simmaron Research, a non-profit organization based in Incline Village, Nevada, which works to advance translational science in treating neuroimmune diseases like CFS/ME.[1]
In 2012, Gottschalk was the Clinical Coordinator for years I and II of the CDC Multi-site Clinical Assessment of CFS. The project's aim was to characterize patients with CFS or myalgic encephalomyelitis (ME) in clinical practices of clinicians with expertise in CFS/ME.[2] Team members included Andreas Kogelnik, Lucinda Bateman, and Nancy Klimas.[3]
In 2012, Gottschalk was the Cohort Recruitment Project Clinical Coordinator at the Chronic Fatigue Initiative at the Hutchins Family Foundation for the project to develop a clinical and biosample database to enable discovery of pathogens and pathogenic mechanisms in Chronic Fatigue Syndrome.[4]
Notable studies[edit | edit source]
- 2015, Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[5] (Full Text)
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[6] (Abstract)
- 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study[7] (Abstract)
- 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[8] - (Full text)
- 2016, Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome[9] (Abstract)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[10] (Full Text)
- 2017, Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations[11] (Full Text)
- 2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations[12] (Full text)
Talks and interviews[edit | edit source]
- 2012, ME/CFS Alert Episode 30 - ME/CFS Alert - Gunnar Gottschalk on ME/CFS Research and Challenges
- 2013, Gave oral presentation on the therapeutic potential of cidofovir at the HHV-6/7 International Conference 2013, Paris France[13]
- 2013, ME/CFS Alert Episode 49 - ME/CFS Alert - Interview with Gunnar Gottschalk
Online presence[edit | edit source]
Learn more[edit | edit source]
- 2013, Taking Fundraising for ME/CFS Research to New Heights - Gunnar Gottschalk and Robert Miller skydive to raise funds for Simmaron Research
See also[edit | edit source]
References[edit | edit source]
- ↑ "Board of Directors". Simmaron Research. Retrieved September 3, 2019.
- ↑ http://www.cdc.gov/cfs/programs/clinical-assessment/
- ↑ https://www.linkedin.com/in/gunnar-gottschalk-86b29837
- ↑ http://cfinitiative.org/research-programs/
- ↑ Peterson, D; Brenu, EW; Gottschalk, G; Ramos, SB; Nguyen, T; Staines, D; Marshall-Gradisnik, S (2015), "Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Mediators of Inflammation, 2015, doi:10.1155/2015/929720
- ↑ Klimas, N.G.; Ironson, G.; Carter, A.; Balbin, E.; Bateman, L.; Felsenstein, D.; Levine, S.; Peterson, D.; Chiu, K.; Allen, A.; Cunningham, K.; Gottschalk, C.G.; Fletcher, M; Hornig, M.; Canning, C.; Komaroff, A.L. (2015), "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome", Fatigue: Biomedicine, Health & Behavior, 3 (2): 75-96, doi:10.1080/21641846.2015.1023652
- ↑ Bateman, L.; Darakjy, S.; Klimas, N.; Peterson, D.; Levine, S.M.; Allen, A.; Carlson, S.A.; Balbin, E.G.; Gottschalk, G.; March, D. (2015), "Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study", Fatigue: Biomedicine, Health & Behavior, 3 (1): 1-15, doi:10.1080/21641846.2014.978109
- ↑ Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
- ↑ Hornig, M; Gottschalk, G; Peterson, D; Knox, KK; Schultz, AF; Eddy, ML; Che, X; Lipkin, WI (2016), "Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome.", Molecular Psychiatry, 21 (2): 261-9, doi:10.1038/mp.2015.29
- ↑ Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
- ↑ Hornig, M; Gottschalk, G; Eddy, ML; Che, X; Ukaigwe, JE; Peterson, DL; Lipkin, WI (2017), "Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations", Translational Psychiatry, 7 (4), doi:10.1038/tp.2017.44
- ↑ Mandarano, Alexandra H.; Maya, Jessica; Giloteaux, Ludovic; Peterson, Daniel L.; Maynard, Marco; Gottschalk, C. Gunnar; Hanson, Maureen R. (March 2, 2020). "Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations". The Journal of Clinical Investigation. 130 (3): 1491–1505. doi:10.1172/JCI132185. ISSN 1558-8238. PMC 7269566. PMID 31830003.
- ↑ https://www.linkedin.com/in/gunnar-gottschalk-86b29837